Skip to main content
Skip to main navigation menu
Skip to site footer
Open Menu
Home
Current
Archives
Manuscript Submission
Announcements
Editorial Review Board
Permissions and Licensing
Subscription Information
Advertising Information
Library Referral Form
Library Referral Form - Online
Reprints
The Future of Opioids
Special Issue on Buprenorphine
Special on Legal and Regulatory Aspects of Opioids
Webinars
BUPE2024
User License Agreement
Call for Papers - Updated
About
About the Journal
Editorial Team
Privacy Statement
Contact
Search
Register
Login
Home
/
Archives
/
Vol. 8 No. 4 (2012): July/August
Vol. 8 No. 4 (2012): July/August
Published:
07/01/2012
Letters to the Editor
Prepping, another cause for diversion of opioids
Frank A. Kunkel, MD, Isabel Ahrendt
205-206
PDF
Advantages of EMBEDA® (morphine sulfate and naltrexone hydrochloride) extended-release capsules in pain management
Shailendra Kapoor, MD
207
PDF
Brief Communication
Extended-release/long-acting opioid REMS may fill the need for prescribers' appropriate use education
Susan C. Nicholson, MD, Kimberly Evanyo, BA, Gregory D. Salinas, PhD, Nancy Roepke, MBA, B. Stephen Burton, MS, Debi Susalka, BS
212-216
PDF
Articles
Morphine clearance in children: Does race or genetics matter?
Senthilkumar Sadhasivam, MD, MPH, Elke H. J. Krekels, MSc, Vidya Chidambaran, MD, Hope R. Esslinger, MPT, Pornswan Ngamprasertwong, MD, Kejian Zhang, MD, MBA, Tsuyoshi Fukuda, PhD, Alexander A. Vinks, PharmD, PhD
217-226
Requires Subscription or Fee
PDF
(USD 56)
Postsurgical patient-controlled opioid self-administration is greater in hospitalized abstinent smokers than nonsmokers
Caren L. Steinmiller, PhD, Christina Diederichs, BS, Timothy A. Roehrs, PhD, Maren Hyde-Nolan, MS, Thomas Roth, PhD, Mark K. Greenwald, PhD
227-235
Requires Subscription or Fee
PDF
(USD 56)
Intranasal sufentanil provides adequate analgesia for emergency department patients with extremity injuries
Robert Stephen, MD, Erin Lingenfelter, PharmD, Camille Broadwater-Hollifield, MPH, Troy Madsen, MD
237-241
Requires Subscription or Fee
PDF
(USD 56)
Clinical effectiveness and safety of OROS® hydromorphone in breakthrough cancer pain treatment: A multicenter, prospective, open-label study in Korean patients
Kyung Hee Lee, MD, Min Kyoung Kim, MD, Myung Soo Hyun, MD, Jin Young Kim, MD, Keon Uk Park, MD, Hong Suk Song, MD, PhD, Sun Ah Lee, MD, Won Sik Lee, MD, Sung Hwa Bae, MD, Hun Mo Ryoo, MD, Yoon Young Cho, MD
243-252
Requires Subscription or Fee
PDF
(USD 56)
Case Studies
High dose of buprenorphine in terminally ill patient with liver failure: Efficacy and tolerability
Alessandra Ciccozzi, MD, Chiara Angeletti, MD, Giada Baldascino, MD, Emiliano Petrucci, MD, Cristina Bonetti, MD, Stefania De Santis, MD, Antonella Paladini, MD, Giustino Varrassi, PhD, Franco Marinangeli, MD
253-259
Requires Subscription or Fee
PDF
(USD 56)
ICOO Conference Information
International Conference on Opioids, June 10-12, 2012
260-261
PDF
Full Issue
Volume 8, Number 4
201-264
Requires Subscription or Fee
PDF
(USD 56)
Old JOM header
ad_block_3
Subscription
Login to access subscriber-only resources.
Make a Submission
Make a Submission
Information
For Readers
For Authors
For Librarians
Keywords
Announcements